Serologic Response to the SARS-CoV-2 (COVID-19) MRNA-1273 Vaccine in Select Subsets of Oncology Patients
Clinical trial NCT04854980 · COMPLETED
Trial details
- NCT number
- NCT04854980
- Sponsor
- University of Rochester
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-08-03
- Primary completion
- 2022-03-15
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.